These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 20817230

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The clinical spectrum of freezing of gait in atypical parkinsonism.
    Factor SA.
    Mov Disord; 2008; 23 Suppl 2():S431-8. PubMed ID: 18668624
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
    Lannuzel A, Höglinger GU, Verhaeghe S, Gire L, Belson S, Escobar-Khondiker M, Poullain P, Oertel WH, Hirsch EC, Dubois B, Ruberg M.
    Brain; 2007 Mar; 130(Pt 3):816-27. PubMed ID: 17303592
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
    Chalmers KA, Love S.
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Significance of MRI in diagnosis and differential diagnosis of Parkinson's disease.
    Mahlknecht P, Hotter A, Hussl A, Esterhammer R, Schocke M, Seppi K.
    Neurodegener Dis; 2010 Nov; 7(5):300-18. PubMed ID: 20616565
    [Abstract] [Full Text] [Related]

  • 36. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy.
    Borroni B, Malinverno M, Gardoni F, Alberici A, Parnetti L, Premi E, Bonuccelli U, Grassi M, Perani D, Calabresi P, Di Luca M, Padovani A.
    Neurology; 2008 Nov 25; 71(22):1796-803. PubMed ID: 18971445
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Visual signs and symptoms of progressive supranuclear palsy.
    Armstrong RA.
    Clin Exp Optom; 2011 Mar 25; 94(2):150-60. PubMed ID: 20629667
    [Abstract] [Full Text] [Related]

  • 40. [Essential points to differentiate various diseases causing parkinsonism].
    Kuzuhara S.
    Nihon Rinsho; 2000 Oct 25; 58(10):2049-53. PubMed ID: 11068445
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.